Login

Innovative PVD Coating Solutions for Hydrogen Applications | Stefan Dreger, President EMEA Hydrogen Solutions Impact Coatings 00:10:00

Share On Facebook Share On Twitter

President:EMEA Hydrogen Solutions, Impact Coatings AB

Recent Videos

00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio

Suggestions

00:10:00
Unlocking Mineral Potential: Arabian & Nubian Shields | Al Workman, Vice President and Owner, Watts, Griffis McOuat Ltd
00:10:00
Shaping Our Destiny: How to Create the Future We Dream Of|Andrew Beebe,Managing Director,Obvious Ventures
00:10:00
Karim Henkens on ICT Group's 2022 Milestones | Karim Henkens, CEO, ICT Group.
00:10:00
Sandstorm Gold President and CEO Nolan Watson discusses company updates, while Remark Holdings, Inc. (NASDAQ: MARK) shares market insights.
00:10:00
Co-Founder of BlackBoxStocks, on Platform Enhancements and New Integrations | Eric Pharis, Founder, BlackBoxStocks Inc.
00:10:00
"Kjell Morten Johnsen is the CEO of Tele2."
00:10:00
Mike Ford on SiteMinder’s Impact and Purpose in the Hotel Industry | Mike Ford, Founder , SiteMinder Ltd.
00:10:00
Revolutionizing Drug Delivery: Medesis Pharma's Breakthrough with Aonys Technology | Jean-Claude Maurel, CEO, Medesis Pharma SA.
00:10:00
Identify and evaluate investment opportunities|Amy Duffuor,Managing Director,Prime Impact Fund
00:00:00
Address how the brain uses sensation to inform action / Sandeep Robert Datta, MD, PhD Professor of Neurobiology, HMS
00:00:00
Medical Supply Shortages - Dr. Pritish Tosh, a Professor of Medicine and Infectious Diseases Physician at Mayo Clinic
00:10:00
Political Risks and Economic Booms: The Future of Infrastructure Investment | Gordon Bajnai, Chairman , Campbell Lutyens.

© 2026 Nehu